Step-by-Step, How to Become Diabetic (Hint: It’s Easy!)
It’s so easy, anyone can do it!
Becoming diabetic and proudly having to finger stick your way to blood sugar control is patriotic, as it builds revenues for Big Pharma. What better way to support your country than to help successful industries grow larger, increase shareholder value, and increase the salary and perks for hard working executives?
So if you want to join the growing ranks of people who are becoming diabetic, now the largest epidemic of chronic disease ever witnessed in the history of the world, here’s what you do:
Cut your fat intake — Because it leaves you unsatiated and hungry, you will ...
Source: Wheat Belly Blog - April 28, 2014 Category: Cardiology Authors: Dr. Davis Tags: Diabetes Source Type: blogs
How to become diabetic
It’s so easy, anyone can do it!
Becoming diabetic and proudly having to finger stick your way to blood sugar control is patriotic, as it builds revenues for Big Pharma. What better way to support your country than to help successful industries grow larger, increase shareholder value, and increase the salary and perks for hard working executives?
So if you want to join the growing ranks of people who are becoming diabetic, now the largest epidemic of chronic disease ever witnessed in the history of the world, here’s what you do:
–Cut your fat intake–Because it leaves you unsatiated and hungry, you ...
Source: Wheat Belly Blog - April 28, 2014 Category: Cardiology Authors: Dr. Davis Tags: Diabetes Source Type: blogs
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio Acquires Tenaxis Medical, Inc.
PARSIPPANY, NJ and MOUNTAIN VIEW, CA -- (Marketwired) -- 04/23/14 -- The Medicines Company (NASDAQ: MDCO) and Tenaxis Medical, Inc. (Tenaxis) today announced an agreement for The Medicines Company to acquire Tenaxis. Tenaxis's sole product, which mechanically seals both human tissue and artificial grafts is approved, but not launched in the US -- having received US PMA approval from the FDA in March 2013 as a vascular sealant. The product is also approved with a European CE Mark as a surgical sealant applicable to cardiovascular, general, urological, and thoracic surgery. The addition of the Tenaxis product adds another so...
Source: Medical Hemostat - April 23, 2014 Category: Technology Consultants Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs
What is an autoinflammatory disease?
During our weekly physician conference, I discussed a patient with a suspected autoinflammatory disease. An elderly male, he had a history of recurrent fevers, hives, and elevated inflammatory markers, which had gone untreated for many years. Eventually, he developed renal amyloidosis, and was finally referred to rheumatology clinic for further evaluation. Although he had many of the classic signs and symptoms of an autoinflammatory disease, his physicians had not recognized it. His kidneys were failing, and he was being prepared to undergo hemodialysis as a result. Even during the case conference, in the prese...
Source: Kevin, M.D. - Medical Weblog - March 23, 2014 Category: Family Physicians Tags: Conditions Rheumatology Source Type: blogs
GETUP! #FOAMTox across the globe
This week, I sat down with Dr Anselm Wong, who amongst many other roles (ED Consultant, Tox Tweeter @AnselmWong1 and Toxicology Fellow at Austin Hospital, Melbourne, Victoria) is the Project Director for GETUP: Global Educational Toxicology Uniting Project.
GETUP is a new initiative, supported by the American College of Medical Toxicology that seeks to connect countries with established clinical toxicology services and countries without clinical toxicologists around the globe. GETUP uses videoconferencing via Google hangouts to connect registered sites on a monthly basis. Presently, sites have registered across the globe i...
Source: Life in the Fast Lane - February 21, 2014 Category: Emergency Medicine Doctors Authors: Joe Rotella Tags: Education Featured Toxicology #FOAMtox GETUP Source Type: blogs
in answer to my question
Deb wrote:t's me again. Ironically I am a health care professional in dialysis and very familiar with ESRD. Because of this I also know too well the outcome of many noncompliant diabetics.Diagnosis of ESRD is only conclusive through examination of a person's blood work, of course. Some physical symptoms include fatigue, muscle aches and cramping, dry and itchy skin, and lessening of urine output. Many ESRD patients still make urine. The blood work tells most conclusively whether the kidneys are efficient in removing toxins from the body. Most diabetics, especially uncontrolled ones, should also be under the care of a nephr...
Source: Wife of a Diabetic - January 22, 2014 Category: Diabetes Source Type: blogs
Baxter’s VIVIA High Dose Hemodialysis System Gets CE Mark
Baxter International (Deerfield, IL) received regulatory approval to bring its VIVIA hemodialysis system to the European market. The device is designed for more comprehensive High Dose hemodialysis which can be performed during short daily sessions or at night while sleeping.
The touchscreen interface was developed for patient use, since the system is intended to stay in the patient’s home, and instructions on the screen include graphical illustrations on how to setup the device, perform treatment, and clean it once done. To help guarantee safety, the VIVIA features a sensor that detects if a needle is dislodged a...
Source: Medgadget - December 27, 2013 Category: Technology Consultants Authors: Editors Tags: Medicine Source Type: blogs
Hepatitis C in Egypt
The following background data on Hepatitis C in Egypt are abstracted from Gideon www.GideonOnline.com and the Gideon e-book series. [1,2] Primary references available on request.
Incidence and Prevalence:
Hepatitis C is the most common cause of chronic liver disease in Egypt. The nationwide carriage rate in 1997 was estimated at 6 to 8 million, or 18.1% of the population – the highest rate in the world.
A study published in 2010 estimated the yearly rate at 500,000 new cases (0.7% of the population); while a study published in 2013 estimated the yearly rate at fewer than 150,000 cases. An analysis published in 2...
Source: GIDEON blog - December 19, 2013 Category: Databases & Libraries Authors: Dr. Stephen Berger Tags: Ebooks Epidemiology ProMED Egypt hepatitis c Source Type: blogs
Terbutaline and Albuterol for Lowering of Plasma Postassium
CONCLUSION: We conclude that in patients with terminal renal failure undergoing maintenance hemodialysis, intravenous bicarbonate is ineffective in lowering plasma potassium rapidly, and epinephrine is effective in only half the patients, whereas insulin in glucose is a fast and reliable form of therapy for hyperkalemic emergencies. Plasma aldosterone levels are appropriate in relationship to plasma potassium levels, and levels of other potassium-influencing hormones are generally normal. ADDepartment of Medicine, Kantonsspital, Aarau, Switzerland.PMID3052050 6 PubMed ...
Source: Dr. Smith's ECG Blog - December 6, 2013 Category: Cardiology Authors: Steve Smith Source Type: blogs
Critical Care Compendium update
LITFL’s Critical Care Compendium is a comprehensive collection of pages concisely covering the core topics and controversies of critical care.
Currently there are almost 1,500 entries with more in the works… Some pages are more developed than others, and all the pages are being constantly revised and improved. Links to new references and online resources are added daily, with an emphasis on those that are free and open access (FOAM!).
These pages originated from the FCICM exam study notes created by Dr Jeremy Fernando in 2011, and have been updated, modified and added to since. As such will be particularly us...
Source: Life in the Fast Lane - November 17, 2013 Category: Emergency Medicine Doctors Authors: Chris Nickson Tags: Critical Care Compendium Education eLearning Emergency Medicine Featured CCC LITFL collection Source Type: blogs
Medtronic Begins to Develop a Portable Kidney Dialysis Device in India
Medtronic is one of the most successful medical device manufacturers in the world. When it cuts a deal to develop a portable kidney dialysis device in India with one of the most successful hospital chains there, you pay attention (see: Has This Medical Leader Hit Health Care's Biggest Jackpot?). Here are the details from a recent article:
Medtronic...is the world's largest pure medical-device maker, but this stable stock has also impressed investors with amazing growth in 2013. Shares of the company are up more than 34% in 2013. Medtronic's a powerful player in the cardiology market and more, but this com...
Source: Lab Soft News - October 16, 2013 Category: Pathologists Authors: Bruce Friedman Tags: Healthcare Business Healthcare Delivery Medical Research Source Type: blogs
No difference in survival with tissue valve in dialysis patients with endocarditis
Infective endocarditis in patients with chronic kidney disease undergoing long term hemodialysis has high mortality. A recent retrospective analysis of United States Renal Data System published in Circulation assessed those who had bacterial endocarditis between 2004 and 2007 [Leither MD et al. Long-term Survival of Dialysis Patients With Bacterial Endocarditis Undergoing Valvular Replacement Surgery in the United States. Circulation. 2013;128:344-351]. During this period, nearly one thousand three hundred of over eleven thousand dialysis patients hospitalized with bacterial endocarditis underwent valve replacement. While ...
Source: Cardiophile MD - July 28, 2013 Category: Cardiology Authors: Prof. Dr. Johnson Francis MD, DM, FACC, FRCP Edin, FRCP London Tags: Cardiac Surgery Source Type: blogs
Hemodialysis for dabigatran removal
(Source: Notes from Dr. RW)
Source: Notes from Dr. RW - July 2, 2013 Category: Internists and Doctors of Medicine Tags: pharmacology toxicology hematology cardiovascular nephrology Source Type: blogs
Implanting a Lab-Grown Blood Vessel
The tissue engineering of large blood vessels is a very different matter from growing the intricate networks of small blood vessels needed to support tissue. The former goal is far less challenging, for one thing, and researchers are thus further along in bringing the creation of new veins and arteries to the clinic. Here is news of progress on that front:
In a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and implanted it into the arm of a patient with end-stage kidney disease. The procedure, the first U.S. clinical trial to test...
Source: Fight Aging! - June 10, 2013 Category: Health Medicine and Bioethics Commentators Authors: Reason Tags: Daily News Source Type: blogs
